Emily E. Mann

Emily practice focuses on guiding clients through mergers and acquisitions, helping structure the sale or purchase to the client’s advantage, and advising clients on corporate finance transactions, corporate governance issues, and general corporate matters.

Emily received her B.A. from the University of North Carolina at Chapel Hill and her J.D. from the University of North Carolina School of Law. Emily also completed a fellowship at Loyola University Chicago School of Law, where she earned an LL.M. in health law.

Representative Experience

• Represented practice management services company in the healthcare sector in a series of add-on acquisitions ranging from $400,000 to $50 million. Continued representation of a practice management services company with respect to ongoing add-on acquisitions, drafting and negotiating employment agreements, and general corporate matters
• Represented an inventory logistics company and its equityholders in a $85 million stock sale to a private equity investment firm
• Represented a grassroots advocacy software provider in a $40 million merger with a public affairs software company to create a cloud-based government relations and public affairs platform
• Represented a global commercial real estate services company in a $4 million asset purchase of two real estate appraisal and advisory services providers
• Represented an environmental and infrastructure services platform in a $2 million acquisition of a data analytics firm

Publications

• Co-Author, The Ethical Use of Observation Units: Empowering Physician Autonomy for Patient Placement Decisions, Houston Journal of Health Law & Policy, July 1, 2022

• Author, Expansive Section 1115 Waivers Are Necessary To Support Essential Health Care Providers Facing Financial Hardship Due To COVID-19, Loyola University Chicago Journal of Regulatory Compliance, Fall 2020
• Author, Advocating for Access: How the Eighth Amendment and the Americans with Disabilities Act Open a Pathway for Opioid-Addicted Inmates to Receive Medication-Assisted Treatment, Annals of Health Law and Life Sciences Advance Directive, Fall 2019